Therefore, the endothelial markers CD31 and CD34 and vascular endothelial growth factor (VEGF) were used in the immunohistochemical detection of angiogenic activity in NSCLC [24]. This evidence concerns the gene PECAM1 and non-small cell lung carcinoma.